About us

Founded in 2010, SilicoLife designs optimized microorganisms and novel pathways for industrial biotechnology applications. Based on metabolic engineering and synthetic biology approaches shortens the development time and costs of new highly effective processes for the production of specific target compounds such as chemicals, food ingredients or biopolymers.

Artificial Intelligence

Biological knowledge

We build computational models of microbial cells and develop proprietary state-of-the-art algorithms to find the most efficient pathways between raw-materials and end-products, streamlining the strain design process and explore non-intuitive pathway modifications.

Leading chemical, materials and synthetic biology companies have chosen SilicoLife as a development partner to maintain their market edge in increasingly competitive markets.

SilicoLife is a spin-off of the MIT Portugal program in Bioengineering and is also a member of P-BIO, Portugal's Bioindustry Organization.